Literature DB >> 10377178

Fundamental signals that regulate eosinophil homing to the gastrointestinal tract.

A Mishra1, S P Hogan, J J Lee, P S Foster, M E Rothenberg.   

Abstract

The histological identification of increased eosinophils in the gastrointestinal tract occurs in numerous clinical disorders; however, there is a limited understanding of the mechanisms regulating eosinophil trafficking into this mucosal surface. The results presented in this study characterize the processes regulating eosinophil homing into the gastrointestinal tract at baseline. Eosinophils were found to be present in the lamina propria of 19-day-old embryos and germ-free adult mice at concentrations comparable to those present in non-germ-free adult mice. Furthermore, eosinophil gastrointestinal levels were not altered by increasing circulating eosinophils after pulmonary allergen challenge. Gastrointestinal eosinophil levels were partially reduced in mice deficient in recombinase activating gene-1 (RAG-1), IL-5, or the beta common chain (betac), but these reductions paralleled reductions in circulating eosinophils. In contrast, mice deficient in eotaxin had a marked reduction in gastrointestinal eosinophils but normal levels of eosinophils in the hematopoietic compartments. Furthermore, eotaxin was important for regulating eosinophil levels, even in the presence of high levels of IL-5. These investigations demonstrate eosinophil homing into the gastrointestinal tract during embryonic development occurring independently of viable intestinal flora. Furthermore, eotaxin is identified as the primary regulator of eosinophil gastrointestinal homing under homeostatic states, and may therefore have a fundamental role in innate immune responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377178      PMCID: PMC408388          DOI: 10.1172/JCI6560

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

Review 1.  Models of intestinal hypersensitivity.

Authors:  A Ferguson
Journal:  Clin Gastroenterol       Date:  1976-05

2.  Purification of an atypical mast cell protease and its levels in developing rats.

Authors:  R G Woodbury; H Neurath
Journal:  Biochemistry       Date:  1978-10-03       Impact factor: 3.162

Review 3.  The immunobiology of eosinophils.

Authors:  P F Weller
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

4.  Association of mastopoiesis with haemopoietic tissues in the neonatal rat.

Authors:  S G Watkins; J L Dearin; L C Young; D I Wilhelm
Journal:  Experientia       Date:  1976-10-15

5.  Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness.

Authors:  E Hamelmann; A Oshiba; J Schwarze; K Bradley; J Loader; G L Larsen; E W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  1997-06       Impact factor: 6.914

6.  Growth and development of "antigen-free" grafts of foetal mouse intestine.

Authors:  A Ferguson; D M Parrott
Journal:  J Pathol       Date:  1972-02       Impact factor: 7.996

Review 7.  The eosinophilic leukocyte: structure and function.

Authors:  G J Gleich; C R Adolphson
Journal:  Adv Immunol       Date:  1986       Impact factor: 3.543

8.  IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity.

Authors:  M E Rothenberg; J Petersen; R L Stevens; D S Silberstein; D T McKenzie; K F Austen; W F Owen
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

9.  Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.

Authors:  W F Owen; M E Rothenberg; D S Silberstein; J C Gasson; R L Stevens; K F Austen; R J Soberman
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

10.  Eosinophilia in transgenic mice expressing interleukin 5.

Authors:  L A Dent; M Strath; A L Mellor; C J Sanderson
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

View more
  139 in total

Review 1.  Gene targeting of chemokines and their receptors.

Authors:  D M Slattery; N Gerard; C Gerard
Journal:  Springer Semin Immunopathol       Date:  2000

2.  52-year-old woman with dysphagia.

Authors:  Sahil Khanna; Amit Noheria; Charles H Rohren
Journal:  Mayo Clin Proc       Date:  2010-08       Impact factor: 7.616

Review 3.  Eosinophils: important players in humoral immunity.

Authors:  C Berek
Journal:  Clin Exp Immunol       Date:  2015-09-28       Impact factor: 4.330

4.  The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.

Authors:  Tomer Adar; Shimon Shteingart; Ami Ben-Ya'acov; Ariella Bar-Gill Shitrit; Dan M Livovsky; Shimrit Shmorak; Mahmud Mahamid; Bernardo Melamud; Fiona Vernea; Eran Goldin
Journal:  Dig Dis Sci       Date:  2016-02-13       Impact factor: 3.199

5.  The role of eosinophils in inflammatory bowel disease.

Authors:  S Al-Haddad; R H Riddell
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

6.  Eosinophil granulocytes are activated during the remission phase of ulcerative colitis.

Authors:  M Lampinen; A Rönnblom; K Amin; G Kristjansson; F Rorsman; P Sangfelt; B Säfsten; M Wagner; A Wanders; O Winqvist; M Carlson
Journal:  Gut       Date:  2005-05-10       Impact factor: 23.059

Review 7.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 8.  Eosinophilic gastroenteritis: a review.

Authors:  Hwa Eun Oh; Runjan Chetty
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

Review 9.  Mechanism of eosinophilic esophagitis.

Authors:  Anil Mishra
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

Review 10.  Chemotactic factors associated with eosinophilic gastrointestinal diseases.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.